Progress of targeted therapy in multiple myeloma / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 709-713, 2016.
Artículo
en Chino
| WPRIM
| ID: wpr-506831
ABSTRACT
Numerous targeted therapies emerged into clinical trials, which improved the response rate and life quality of multiple myeloma (MM) patients. Series latest developments at targeted therapy for MM patients were reported on 58th American Society of Hematology (ASH) Annual Meeting, especially the results of combination with these novel agents showed a major highlight of this meeting. The advances in the novel targeted and biological therapies will be summarized in this paper.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of Leukemia & Lymphoma
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS